Find Scholarly Works

Search in all content

Filters for Scholarly Works

Search concepts
Selected Filters

Publication Year

  • 2019
  • 2016
  • 2014
  • 2011

Author

  • Keith Lindor
2019
5 Scopus citations

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Chascsa, D. M. & Lindor, K. D., Sep 1 2019, In : Minerva gastroenterologica e dietologica. 65, 3, p. 214-228 15 p.

Research output: Contribution to journalArticle

2 Scopus citations

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

Fung, B. M., Lindor, K. & Tabibian, J. H., 2019, In : World journal of gastroenterology. 25, 6, p. 659-671 13 p.

Research output: Contribution to journalReview article

13 Scopus citations

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K., Everson, G. T. & Bowlus, C. L., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Current and promising therapy for primary biliary cholangitis

Gossard, A. A. & Lindor, K., Jun 13 2019, In : Expert Opinion on Pharmacotherapy. 20, 9, p. 1161-1167 7 p.

Research output: Contribution to journalReview article

3 Scopus citations
8 Scopus citations

Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study

Eaton, J. E., Nelson, K. M., Gossard, A. A., Carey, E. J., Tabibian, J. H., Lindor, K. D. & LaRusso, N. F., May 4 2019, In : Scandinavian Journal of Gastroenterology. 54, 5, p. 633-639 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
7 Scopus citations

Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices

Dong, T. S., Kalani, A., Aby, E. S., Le, L., Luu, K., Hauer, M., Kamath, R., Lindor, K. & Tabibian, J. H., Aug 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 9, p. 1894-1901.e1

Research output: Contribution to journalArticle

5 Scopus citations

NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A nebulous matter

Tabibian, J. H. & Lindor, K., Jan 1 2019, (Accepted/In press) In : Journal of Hepatology.

Research output: Contribution to journalArticle

3 Scopus citations

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Lindor, K., Bowlus, C. L., Boyer, J., Levy, C. & Mayo, M., Jan 2019, In : Hepatology. 69, 1, p. 394-419 26 p.

Research output: Contribution to journalArticle

78 Scopus citations

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

Harms, M. H., van Buuren, H. R., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K. D., Hirschfield, G. M., Parés, A., Floreani, A., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Nevens, F., Ponsioen, C. Y., Mason, A. L., Kowdley, K. V., Lammers, W. J., Hansen, B. E. & van der Meer, A. J., Aug 2019, In : Journal of Hepatology. 71, 2, p. 357-365 9 p.

Research output: Contribution to journalArticle

20 Scopus citations
2016

Advances in primary sclerosing cholangitis

Horsley-Silva, J. L., Carey, E. J. & Lindor, K., 2016, In : The Lancet Gastroenterology and Hepatology. 1, 1, p. 68-77 10 p.

Research output: Contribution to journalReview article

11 Scopus citations

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis

Hilscher, M., Enders, F. B., Carey, E. J., Lindor, K. & Tabibian, J. H., Mar 1 2016, In : Annals of Hepatology. 15, 2, p. 246-253 8 p.

Research output: Contribution to journalArticle

25 Scopus citations

A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis

Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., Trauner, M., Jones, D. E., Floreani, A., Hohenester, S., Luketic, V., Shiffman, M., Van Erpecum, K. J., Vargas, V., Vincent, C., Hirschfield, G. M. & 12 others, Shah, H., Hansen, B., Lindor, K., Marschall, H. U., Kowdley, K. V., Hooshmand-Rad, R., Marmon, T., Sheeron, S., Pencek, R., MacConell, L., Pruzanski, M. & Shapiro, D., Aug 18 2016, In : New England Journal of Medicine. 375, 7, p. 631-643 13 p.

Research output: Contribution to journalArticle

367 Scopus citations

Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis

Quinn, K. P., Tabibian, J. H. & Lindor, K., Dec 1 2016, (Accepted/In press) In : Scandinavian Journal of Gastroenterology. p. 1-5 5 p.

Research output: Contribution to journalArticle

11 Scopus citations

Distinguishing immunoglobulin G4–related disease from its pancreatobiliary mimics: Are we there now?

Tabibian, J. H. & Lindor, K., Aug 1 2016, In : Hepatology. 64, 2, p. 340-343 4 p.

Research output: Contribution to journalEditorial

6 Scopus citations

Emerging drugs for the treatment of Primary Biliary Cholangitis

Ali, A. H., Tabibian, J. H., Carey, E. J. & Lindor, K., Jan 2 2016, In : Expert Opinion on Emerging Drugs. 21, 1, p. 39-56 18 p.

Research output: Contribution to journalArticle

12 Scopus citations

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Journal of Hepatology. 65, 4, p. 661-662 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Hepatology. 64, 4, p. 1031-1032 2 p.

Research output: Contribution to journalEditorial

4 Scopus citations

Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis

Juliusson, G., Imam, M., Björnsson, E. S., Talwalkar, J. A. & Lindor, K., Jun 2 2016, In : Scandinavian Journal of Gastroenterology. 51, 6, p. 745-752 8 p.

Research output: Contribution to journalArticle

13 Scopus citations

Novel treatments in primary sclerosing cholangitis

Ali, A. H. & Lindor, K., Nov 1 2016, In : Clinical Liver Disease. 8, 5, p. 132-135 4 p.

Research output: Contribution to journalReview article

1 Scopus citations

Obeticholic acid for the treatment of primary biliary cholangitis

Ali, A. H. & Lindor, K., Sep 1 2016, In : Expert Opinion on Pharmacotherapy. 17, 13, p. 1809-1815 7 p.

Research output: Contribution to journalReview article

23 Scopus citations

Oral vancomycin therapy in a child with primary sclerosing cholangitis and severe ulcerative colitis

Buness, C., Lindor, K. & Miloh, T., Jan 1 2016, In : Pediatric Gastroenterology, Hepatology and Nutrition. 19, 3, p. 210-213 4 p.

Research output: Contribution to journalArticle

7 Scopus citations

Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)

Chawla, K. S., Talwalkar, J. A., Keach, J. C., Malinchoc, M., Lindor, K. & Jorgensen, R., Dec 31 2016, In : BMJ Open Gastroenterology. 3, 1, e000069.

Research output: Contribution to journalArticle

21 Scopus citations

Shifting Paradigms: What Is the True Prevalence and Clinical Course of Primary Sclerosing Cholangitis?

Weersma, R. K. & Lindor, K., Oct 1 2016, In : Gastroenterology. 151, 4, p. 590-593 4 p.

Research output: Contribution to journalEditorial

5 Scopus citations

Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: A multicentre international study

Trivedi, P. J., Lammers, W. J., Van Buuren, H. R., Parés, A., Floreani, A., Janssen, H. L. A., Invernizzi, P., Battezzati, P. M., Ponsioen, C. Y., Corpechot, C., Poupon, R., Mayo, M. J., Burroughs, A. K., Nevens, F., Mason, A. L., Kowdley, K. V., Lleo, A., Caballeria, L., Lindor, K., Hansen, B. E. & 1 others, Hirschfield, G. M., Feb 1 2016, In : Gut. 65, 2, p. 321-329 9 p.

Research output: Contribution to journalArticle

75 Scopus citations

Targets and investigative treatments for primary biliary cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., Oct 2 2016, In : Expert Opinion on Orphan Drugs. 4, 10, p. 1011-1020 10 p.

Research output: Contribution to journalReview article

The authors reply

Nevens, F., Lindor, K. & Jones, D. E., Nov 17 2016, In : New England Journal of Medicine. 375, 20, p. e41

Research output: Contribution to journalLetter

4 Scopus citations

The management of autoimmunity in patients with cholestatic liver diseases

Ali, A. H., Carey, E. J. & Lindor, K., Jan 2 2016, (Accepted/In press) In : Expert Review of Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

7 Scopus citations

The Microbiome and Primary Sclerosing Cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., Sep 1 2016, In : Seminars in Liver Disease. 36, 4, p. 340-348 9 p.

Research output: Contribution to journalArticle

7 Scopus citations

Ursodeoxycholic acid treatment in primary sclerosing cholangitis

Tabibian, J. H. & Lindor, K., Jan 1 2016, Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Developments. Springer International Publishing, p. 145-152 8 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study

PURIFI Study Group, Jul 1 2016, In : Hepatology. 64, 1, p. 189-199 11 p.

Research output: Contribution to journalArticle

53 Scopus citations
2014

An overview of current and future therapeutic strategies for the treatment of primary sclerosing cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., Jun 2014, In : Expert Opinion on Orphan Drugs. 2, 6, p. 545-556 12 p.

Research output: Contribution to journalReview article

2 Scopus citations

Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis

Tabibian, J. H., Enders, F., Imam, M. H., Kolar, G., Lindor, K. & Talwalkar, J. A., 2014, In : Annals of Hepatology. 13, 3, p. 384-389 6 p.

Research output: Contribution to journalArticle

Open Access
11 Scopus citations

Association of adiposity, measures of metabolic dysregulation, and elevated alanine aminotransferase in subjects with normal body mass index

Treeprasertsuk, S., Romero-Corral, A., Somers, V. K., Sierra-Johnson, J., Lindor, K. D., Angulo, P. & Lopez-Jimenez, F., Oct 1 2014, In : Asian Biomedicine. 8, 5, p. 585-595 11 p.

Research output: Contribution to journalArticle

Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis

Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., George, J., Barrera, F., Haflidadóttir, S., Björnsson, E. S., Armstrong, M. J., Hopkins, L. J., Gao, X., Francque, S., Verrijken, A., Yilmaz, Y. & 13 others, Lindor, K. D., Charlton, M., Haring, R., Lerch, M. M., Rettig, R., Völzke, H., Ryu, S., Li, G., Wong, L. L., Machado, M., Cortez-Pinto, H., Yasui, K. & Cassader, M., Jul 2014, In : PLoS Medicine. 11, 7, e1001680.

Research output: Contribution to journalArticle

233 Scopus citations

Clinical spectrum and management

Björnsson, E. S. & Lindor, K., Feb 1 2014, Autoimmune (IgG4-Related) Pancreatitis and Cholangitis. Springer New York, p. 171-179 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Diagnosis and management of primary biliary cirrhosis

Ali, A. H., Carey, E. J. & Lindor, K., Dec 1 2014, In : Expert Review of Clinical Immunology. 10, 12, p. 1667-1678 12 p.

Research output: Contribution to journalReview article

5 Scopus citations

Foreword

Lindor, K., Jan 1 2014, In : Unknown Journal. p. vii-viii

Research output: Contribution to journalArticle

Hepatocellular carcinoma: Low risk of HCC in patients who have PSC and cirrhosis

Gossard, A. A. & Lindor, K., May 2014, In : Nature Reviews Gastroenterology and Hepatology. 11, 5, p. 276-277 2 p.

Research output: Contribution to journalArticle

6 Scopus citations

Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

Global PBC Study Group, Dec 1 2014, In : Gastroenterology. 147, 6, p. 1338-1349.e5

Research output: Contribution to journalArticle

175 Scopus citations

Magic wand and crystal ball for primary sclerosing cholangitis

Vuppalanchi, R. & Lindor, K., Apr 2014, In : Gastroenterology. 146, 4, p. 890-892 3 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis

Imam, M. H., Eaton, J. E., Puckett, J. S., Loftus, E. V., Mathis, K. L., Gossard, A. A., Talwalkar, J. A. & Lindor, K., Oct 1 2014, In : Journal of Crohn's and Colitis. 8, 10, p. 1294-1299 6 p.

Research output: Contribution to journalArticle

15 Scopus citations

Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis

Silveira, M. G. & Lindor, K., Feb 1 2014, In : Expert Opinion on Pharmacotherapy. 15, 3, p. 365-372 8 p.

Research output: Contribution to journalReview article

30 Scopus citations

Primary biliary cirrhosis in adults

Momah, N. & Lindor, K., May 2014, In : Expert Review of Gastroenterology and Hepatology. 8, 4, p. 427-433 7 p.

Research output: Contribution to journalReview article

19 Scopus citations

Primary sclerosing cholangitis and the microbiota: Current knowledge and perspectives on etiopathogenesis and emerging therapies

Tabibian, J. H., O'Hara, S. P. & Lindor, K., Aug 2014, In : Scandinavian Journal of Gastroenterology. 49, 8, p. 901-908 8 p.

Research output: Contribution to journalReview article

52 Scopus citations

The natural history of primary biliary cirrhosis

Imam, M. H. & Lindor, K., Aug 2014, In : Seminars in Liver Disease. 34, 3, p. 329-333 5 p.

Research output: Contribution to journalArticle

25 Scopus citations

Ursodeoxycholic acid in primary sclerosing cholangitis: If withdrawal is bad, then administration is good (right?)

Tabibian, J. H. & Lindor, K., Sep 2014, In : Hepatology. 60, 3, p. 785-788 4 p.

Research output: Contribution to journalArticle

26 Scopus citations
2011

Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis

Stanich, P. P., Björnsson, E., Gossard, A. A., Enders, F., Jorgensen, R. & Lindor, K. D., Apr 2011, In : Digestive and Liver Disease. 43, 4, p. 309-313 5 p.

Research output: Contribution to journalArticle

104 Scopus citations